Intralesional Corticosteroids for Long-term Control of Primary Cutaneous Marginal Zone Lymphoma without systemic involvement

Authors

Pragya Tiwari, Ravindra Nath Tagore Medical College, Udaipur, IndiaFollow
John Hall, St. Luke's Hospital, University of Missouri, KansasFollow
Anand Rajpara, University of Kansas Medical Centre, Kansas CityFollow
Carol Stanford, University of Missouri, KansasFollow
Daniel Aires, University of Kansas Medical Centre, Kansas CityFollow

Author Credentials

Pragya Tiwari MBBS John Hall MD Anand Rajpara MD, FAAD Daniel Aires MD Carol Stanford MD, FACP

Keywords

primary cutaneous marginal zone lymphoma, cutaneous B-cell lymphoma, pcmzl, marginal zone lymphoma, intralesional corticosteroids

Disciplines

Dermatology | Medicine and Health Sciences

Abstract

Primary cutaneous marginal zone lymphoma (PCMZL) is a B cell lymphoma with a very low metastatic rate. Radiographic monitoring for internal involvement may be indicated initially. Favored treatments include radiation and excision. Radiation has high risk of local recurrence. Excision carries risk of infection and scarring. We report successful long-term treatment of recurrent PCMZL via intralesional steroid injections into new lesions as they arose. This was preferred by the patient over her prior radiation and surgical treatments. Intralesional steroids have the advantages of being simple and well tolerated, without exposure to ionizing radiation, or to the infection and scarring associated with surgery.

Recommended Citation

Tiwari P, Hall J, Rajpara A, Stanford C, Aires D. Intralesional Corticosteroids for Long-term Control of Primary Cutaneous Marginal Zone Lymphoma without systemic involvement. Marshall J Med. 2019; 5(3): 16 DOI: https://doi.org/10.33470/2379-9536.1216.